Kanner Steven 4
4 · Caribou Biosciences, Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
Kanner Steven
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-06$2.69/sh+30,577$82,252→ 354,037 total - Exercise/Conversion
Option to purchase Common Stock
2024-02-06−30,577→ 21,623 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (30,577 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.